Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

J. Brooks Jackson(Johns Hopkins University), Philippa Musoke(Makerere University), Thomas R. Fleming(Fred Hutch Cancer Center), Laura Guay(Johns Hopkins Medicine), Danstan Bagenda(Makerere University), Melissa Allen(Family Health International 360), Clemensia Nakabiito(Makerere University), Joseph Sherman(Johns Hopkins Medicine), Paul Bakaki(Makerere University), Maxensia Owor(Makerere University), Constance Ducar(Johns Hopkins University), Martina Deseyve(Fred Hutch Cancer Center), Anthony Mwatha(Fred Hutch Cancer Center), Lynda Emel(Fred Hutch Cancer Center), Corey Duefield(Johns Hopkins University), Mark Mirochnick(Boston University), Mary Glenn Fowler(Office of AIDS Research), Lynne Mofenson(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Paolo Miotti(Office of AIDS Research), Maria Gigliotti(Boehringer Ingelheim (Germany)), Dorothy Bray(GlaxoSmithKline (Netherlands)), Francis Mmiro(Makerere University)
The Lancet
September 1, 2003
Cited by 525

Abstract


Related Papers

No related papers found

Powered by citation graph analysis